Nancy Hutson

Track

Insider profile

Currently holds positions in Clearside Biomedical Inc and BioCryst Pharmaceuticals Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
8 88% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Clearside Biomedical Inc April 21, 2020 -
Independent Director BioCryst Pharmaceuticals Inc Jan. 20, 2012 -
Independent Director Cubist Pharmaceuticals LLC June 12, 2008 - Jan. 21, 2015
Nancy Hutson's trades of BioCryst Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-16 2024-12-13
PlS Planned sale
5,492 +8.0%
20.05
US$3,126,276 		5,492 +8.0% 20.05 US$3,126,276
2024-12-13 2024-12-13
PrS Proposed sale
6,098
357.26
US$3,266,499 		6,098 357.26 US$3,266,499
2024-05-22 2024-05-20
B Purchase
48,264 -12.4%
181.04
US$565,976 		48,264 -12.4% 181.04 US$565,976
2023-10-04 2023-10-03
B Purchase
10,000 +12.0%
0.86
US$8,600 		10,000 +12.0% 0.86 US$8,600
2023-06-15 2023-06-14
S Sale
12,866 -13.6%
8.04
US$103,443 		12,866 -13.6% 8.04 US$103,443
2023-06-14 2023-06-14
PrS Proposed sale
12,866
8.08
US$103,957 		12,866 8.08 US$103,957
2022-11-21 2022-11-17
B Purchase
30,000 +56.6%
1.33
US$39,900 		30,000 +56.6% 1.33 US$39,900
2021-10-19 2021-10-15
PlS Planned sale
105,000 -61.7%
15.40
US$1,617,000 		105,000 -61.7% 15.40 US$1,617,000
2021-08-17 2021-08-16
B Purchase
3,000 +30.0%
5.68
US$17,040 		3,000 +30.0% 5.68 US$17,040
2021-06-14 2021-06-10
PlS Planned sale
23,333 -26.4%
16.86
US$393,394 		23,333 -26.4% 16.86 US$393,394
2021-03-15 2021-03-12
B Purchase
5,000 +100.0%
3.11
US$15,525 		5,000 +100.0% 3.11 US$15,525
2020-05-21 2020-05-20
B Purchase
5,000 +inf%
1.85
US$9,250 		5,000 +inf% 1.85 US$9,250
2018-12-17 2018-12-17
B Purchase
1,000 +inf%
4.46
US$4,460 		1,000 +inf% 4.46 US$4,460